The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Synergistic effects of the PARP inhibitor olaparib and pharmacological ascorbate in castration-resistant prostate cancer.
 
Nicolas Gordon
No Relationships to Disclose
 
Matthew Joseph Schiewer
No Relationships to Disclose
 
Peter Gallagher
No Relationships to Disclose
 
Amy C Mandigo
No Relationships to Disclose
 
Emanuela Dylgjeri
No Relationships to Disclose
 
Christopher McNair
No Relationships to Disclose
 
Renee De Leeuw
No Relationships to Disclose
 
Jennifer K Jones
No Relationships to Disclose
 
Neermala Poudel Neupane
No Relationships to Disclose
 
Ayesha A Shafi
No Relationships to Disclose
 
Lucas Brand
No Relationships to Disclose
 
William Kevin Kelly
Honoraria - Sanofi
Consulting or Advisory Role - Sanofi
Research Funding - Janssen Oncology (Inst); Novartis (Inst); Sanofi (Inst)
Other Relationship - Sanofi
 
Karen E. Knudsen
Honoraria - CellCentric; Janssen Oncology; Sanofi
Consulting or Advisory Role - Atrin Pharmaceuticals; CellCentric; Janssen Oncology; Sanofi
Research Funding - Celgene
Travel, Accommodations, Expenses - Genentech; Sanofi